UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hyperhidrosis and its impact on those living with it

The American journal of managed care, 2018-12, Vol.24 (23 Suppl), p.S491-S495

2018

Volltextzugriff (PDF)

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

The Lancet (British edition), 2022-07, Vol.400 (10348), p.273-282

2022

Volltextzugriff (PDF)

Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type

Annals of allergy, asthma, & immunology, 2024-03, Vol.132 (3), p.383-389.e3

2024

Volltextzugriff (PDF)

Regression of diffuse B‐cell lymphoma of the leg with intralesional gentian violet

Experimental dermatology, 2018-01, Vol.27 (1), p.93-95

2018

Volltextzugriff (PDF)

Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary

Immunotherapy, 2023-09, Vol.15 (13), p.975-980

2023

Volltextzugriff (PDF)

Effects of total-body digital photography on cancer worry in patients with atypical mole syndrome

JAMA dermatology (Chicago, Ill.), 2015-02, Vol.151 (2), p.137

2015

Volltextzugriff (PDF)

Resource Utilization and Quality of Life Associated with Congenital Ichthyoses

Pediatric dermatology, 2011-09, Vol.28 (5), p.512-518

2011

Volltextzugriff (PDF)

Utilization and rationale for the implementation of total body (digital) photography as an adjunct screening measure for melanoma

Melanoma research, 2010-10, Vol.20 (5), p.417-421

2010

Volltextzugriff (PDF)

Reliable Methods to Evaluate the Clinical Severity of Ichthyosis

Pediatric dermatology, 2010-03, Vol.27 (2), p.148-153

2010

Volltextzugriff (PDF)

Quality of Life of Cutaneous Disease in the Ectodermal Dysplasias

Pediatric dermatology, 2010-05, Vol.27 (3), p.260-265

2010

Volltextzugriff (PDF)

Annual Direct and Indirect Health Costs of the Congenital Ichthyoses

Pediatric dermatology, 2010-07, Vol.27 (4), p.325-336

2010

Volltextzugriff (PDF)

52871 Tapinarof Cream 1% Once Daily is Efficacious for the Treatment of Moderate to Severe Atopic Dermatitis in Patients with Skin of Color Down to 2 Years of Age in Two Pivotal Phase 3 Trials

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB321-AB321

2024

Volltextzugriff (PDF)

52853 Impact of Baseline Disease Severity on the Long-Term Efficacy of Abrocitinib Treatment in Patients With Moderate-To-Severe Atopic Dermatitis: Interim Analysis of the Long-Term Extension JADE EXTEND Study

Journal of the American Academy of Dermatology, 2024-09, Vol.91 (3), p.AB232-AB232

2024

Volltextzugriff (PDF)

670 - Tapinarof cream 1% once daily is efficacious for the treatment of atopic dermatitis in patients with skin of color down to 2 years of age in two pivotal phase 3 trials

British journal of dermatology (1951), 2024-08, Vol.191 (Supplement_2)

2024

Volltextzugriff (PDF)

32496 Efficacy and safety of abrocitinib according to geographies

Journal of the American Academy of Dermatology, 2022-09, Vol.87 (3), p.AB161-AB161

2022

Volltextzugriff (PDF)

The New Face of Preadolescent and Adolescent Acne: Beyond the Guidelines

The Journal of Family Practice, 2022-07, Vol.71 (6), p.S63-S70

2022

Volltextzugriff (PDF)

Tapinarof Cream 1% Once Daily is Efficacious for the Treatment of Atopic Dermatitis in Patients with Skin of Color Down to 2 Years of Age in Two Pivotal Phase 3 Trials

Skin (Milwood, N.Y.), 2024-07, Vol.8 (4), p.s411

2024

Volltextzugriff (PDF)

Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis

Skin (Milwood, N.Y.), 2023-03, Vol.7 (2), p.s154

2023

Volltextzugriff (PDF)

Investigating Treatment of Primary Axillary Hyperhidrosis With a Topical Retrometabolic Anticholinergic Drug

Skin (Milwood, N.Y.), 2021-11, Vol.5 (6), p.s74

2021

Volltextzugriff (PDF)

Non-Prescription Treatment Options

Advances in experimental medicine and biology, 2017, Vol.1027, p.121-137

2017

Volltextzugriff (PDF)

Annual Direct and Indirect Health Costs of the Congenital Ichthyoses: Cost of Congenital Ichthyoses

Pediatric dermatology, 2010-07, Vol.27 (4), p.325-336

2010

Volltextzugriff (PDF)

Quality of Life of Cutaneous Disease in the Ectodermal Dysplasias: Quality of Life in Ectodermal Dysplasias

Pediatric dermatology, 2010-05, Vol.27 (3), p.260-265

2010

Volltextzugriff (PDF)

Classic Skin Manifestations

Essentials of Gastroenterology, 2012, p.418-428

2012

Volltextzugriff (PDF)

Regression of diffuse B-cell lymphoma of the leg with intralesional gentian violet

Experimental dermatology, 2018, Vol.27 (1), p.93-95

2018

Volltextzugriff (PDF)

Classic Skin Manifestations

Sitaraman and Friedman's Essentials of Gastroenterology, 2017, p.399-411

2017

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Hyperhidrosis and its impact on those living with it

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial

Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type

Regression of diffuse B‐cell lymphoma of the leg with intralesional gentian violet

Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summary

Effects of total-body digital photography on cancer worry in patients with atypical mole syndrome

Resource Utilization and Quality of Life Associated with Congenital Ichthyoses

Utilization and rationale for the implementation of total body (digital) photography as an adjunct screening measure for melanoma

Reliable Methods to Evaluate the Clinical Severity of Ichthyosis

Quality of Life of Cutaneous Disease in the Ectodermal Dysplasias

Annual Direct and Indirect Health Costs of the Congenital Ichthyoses

52871 Tapinarof Cream 1% Once Daily is Efficacious for the Treatment of Moderate to Severe Atopic Dermatitis in Patients with Skin of Color Down to 2 Years of Age in Two Pivotal Phase 3 Trials

52853 Impact of Baseline Disease Severity on the Long-Term Efficacy of Abrocitinib Treatment in Patients With Moderate-To-Severe Atopic Dermatitis: Interim Analysis of the Long-Term Extension JADE EXTEND Study

670 - Tapinarof cream 1% once daily is efficacious for the treatment of atopic dermatitis in patients with skin of color down to 2 years of age in two pivotal phase 3 trials

32496 Efficacy and safety of abrocitinib according to geographies

The New Face of Preadolescent and Adolescent Acne: Beyond the Guidelines

Tapinarof Cream 1% Once Daily is Efficacious for the Treatment of Atopic Dermatitis in Patients with Skin of Color Down to 2 Years of Age in Two Pivotal Phase 3 Trials

Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis

Investigating Treatment of Primary Axillary Hyperhidrosis With a Topical Retrometabolic Anticholinergic Drug

Non-Prescription Treatment Options

Annual Direct and Indirect Health Costs of the Congenital Ichthyoses: Cost of Congenital Ichthyoses

Quality of Life of Cutaneous Disease in the Ectodermal Dysplasias: Quality of Life in Ectodermal Dysplasias

Classic Skin Manifestations

Regression of diffuse B-cell lymphoma of the leg with intralesional gentian violet

Classic Skin Manifestations

Suchergebnisse filtern